SALUS, Ljubljana, d. d. (LJSE:SALR)

Slovenia flag Slovenia · Delayed Price · Currency is EUR
62.00
-0.40 (-0.64%)
At close: Apr 28, 2026
108.45%
Market Cap 509.59M
Revenue (ttm) 696.19M
Net Income (ttm) 16.68M
Shares Out 8.22M
EPS (ttm) 2.03
PE Ratio 30.55
Forward PE n/a
Dividend 1.20 (1.90%)
Ex-Dividend Date Apr 28, 2026
Volume 799
Average Volume 1,016
Open 61.50
Previous Close 62.40
Day's Range 61.50 - 63.00
52-Week Range 28.97 - 72.50
Beta 0.59
RSI 43.92
Earnings Date May 7, 2026

About SALUS, Ljubljana, d. d.

SALUS, Ljubljana, d. d. engages in the distribution, promotion, sales services, and value-added services for medicinal products or medical devices in Slovenia and internationally. The company offers commercial partnerships to pharmaceutical, biotechnology, consumer healthcare, and medical device companies; and medicinal products, medical devices, sanitary products, dietary supplements, cosmetics, pharmaceutical packaging, and other products to pharmacies, hospitals, community health centers, residential homes for the elderly, veterinary institu... [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries
Founded 1969
Employees 723
Stock Exchange Ljubljana Stock Exchange
Ticker Symbol SALR
Full Company Profile

Financial Performance

In 2025, SALUS, Ljubljana, d. d.'s revenue was 696.19 million, an increase of 7.30% compared to the previous year's 648.83 million. Earnings were 16.68 million, an increase of 29.78%.

Financial Statements

News

There is no news available yet.